Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GBS Inc. stock logo
GBS
GBS
$1.90
-4.0%
$1.36
$0.36
$2.89
$28.29M1.32955,325 shs148,759 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.34
-5.6%
$2.46
$0.82
$3.38
$85.13M1.141.73 million shs1.33 million shs
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
$2.66
+1.1%
$2.65
$1.92
$4.21
$94.93M0.42248,406 shs46,058 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.81
-3.2%
$4.66
$4.01
$9.33
$79.10M1.32195,385 shs46,468 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GBS Inc. stock logo
GBS
GBS
-4.04%+18.75%+57.02%-10.38%-15.18%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-5.65%-16.73%-4.88%+51.95%+114.68%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
+1.14%+4.72%+6.40%+14.16%+26.07%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-3.22%-2.24%-0.21%+3.44%-11.74%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
1.9545 of 5 stars
3.52.00.00.02.80.00.6
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
2.9328 of 5 stars
3.83.00.00.02.71.70.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.5022 of 5 stars
3.62.00.00.02.90.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GBS Inc. stock logo
GBS
GBS
0.00
N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00284.62% Upside
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
3.50
Strong Buy$5.40103.01% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67142.55% Upside

Current Analyst Ratings Breakdown

Latest GBS, MGRM, MBOT, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/18/2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$5.40
3/18/2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$4.00 ➝ $5.40
(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GBS Inc. stock logo
GBS
GBS
$440K64.30N/AN/A$0.44 per share4.32
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.38 per shareN/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
$365.00K260.08N/AN/A$0.43 per share6.19
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$39.49M2.00$0.05 per share96.29$2.98 per share1.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GBS Inc. stock logo
GBS
GBS
-$8.31M-$0.56N/AN/AN/AN/A-85.64%-54.42%N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$10.74M-$0.65N/AN/AN/AN/A-218.30%-158.17%8/13/2025 (Estimated)
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$13.74M-$0.45N/AN/AN/AN/A-130.90%-106.38%8/13/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1012.0320.91N/A15.90%12.60%11.38%8/6/2025 (Estimated)

Latest GBS, MGRM, MBOT, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/14/2025Q1 2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.12-$0.10+$0.02-$0.10N/AN/A
3/26/2025Q4 2024
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.18-$0.20-$0.02-$0.20N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GBS Inc. stock logo
GBS
GBS
N/A
2.33
2.33
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
3.64
3.64
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
N/A
7.31
7.31
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
10.52
7.89

Institutional Ownership

CompanyInstitutional Ownership
GBS Inc. stock logo
GBS
GBS
2.79%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
0.45%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
GBS Inc. stock logo
GBS
GBS
0.27%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
28.10%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
GBS Inc. stock logo
GBS
GBS
714.89 million14.85 millionNot Optionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million25.64 millionOptionable
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
2835.69 million24.67 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.45 million14.85 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
GBS stock logo

GBS NYSE:GBS

$1.90 -0.08 (-4.04%)
As of 06/12/2025

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.34 -0.14 (-5.65%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$2.34 0.00 (0.00%)
As of 06/13/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Monogram Orthopaedics stock logo

Monogram Orthopaedics NASDAQ:MGRM

$2.66 +0.03 (+1.14%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$2.66 +0.00 (+0.19%)
As of 06/13/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.81 -0.16 (-3.22%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$4.80 0.00 (-0.10%)
As of 06/13/2025 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.